Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

R.L. Piekarz, R. Frye, M. Turner, J.J. Wright, S.L. Allen, M.H. Kirschbaum, J. Zain, H.M. Prince, J.P. Leonard, L.J. Geskin, C. Reeder, David Joske, W.D. Figg, E.R. Gardner, S.M. Steinberg, E.S. Jaffe, M. Stetler-Stevenson, S. Lade, A.T. Fojo, S.E. Bates

    Research output: Contribution to journalArticle

    537 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)5410-5417
    JournalJournal of Clinical Oncology
    Volume27
    Issue number32
    DOIs
    Publication statusPublished - 2009

    Cite this